ERB-041, a selective ERβ agonist, inhibits iNOS production in LPS-activated peritoneal macrophages of endometriosis via suppression of NF-κB activation
ERB-041, a selective ERβ agonist, was found to inhibit inducible nitric oxide synthase (iNOS) production in lipopolysaccharide (LPS)-activated peritoneal macrophages from endometriosis patients by suppressing NF-κB activation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- A selective estrogen receptor-β agonist causes lesion regression in an experimentally induced model of endometriosis via openalex
- Endometriosis as a model for inflammation–hormone interactions in ovarian and breast cancers via openalex
- Immunobiology of endometriosis via openalex
- Macrophages are activated by 17b-estradiol: possible permission role in endometriosis via openalex
- Peritoneal fluid from endometriosis patients switches differentiation of monocytes from dendritic cells to macrophages via openalex
- Role of Estrogens in Inflammatory Response via openalex
- W2012139589 via openalex
- W2013015384 via openalex
- W2016706918 via openalex
- W2070454626 via openalex
- W2075777731 via openalex
- W2084142018 via openalex
- W2087037893 via openalex
- W2106625687 via openalex
- W2112444654 via openalex
- W2115806973 via openalex
- W2132911524 via openalex
- W2136600170 via openalex
- W2137773942 via openalex
- W2143266163 via openalex
- W2164516260 via openalex
- W2167782689 via openalex
- W1647868114 via openalex
- W2172287852 via openalex
- W1966545100 via openalex
- W1968124340 via openalex
- W2001286676 via openalex
- W2002737481 via openalex
- W2006347202 via openalex
Cited by (16)
- Chrysin-loaded PLGA nanoparticles alleviate the implantation of endometriotic lesions via attenuation of peritoneal inflammation and downregulating NF-κB activation-driven expression of angiogenic factors 2025
- An Update on the Multifaceted Role of NF-kappaB in Endometriosis 2022
- Advances in targeting estrogen synthesis and receptors in patients with endometriosis 2022
- YAP1 inhibits ovarian endometriosis stromal cell invasion through ESR2 2020
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? 2018
- Dysfunctional signaling underlying endometriosis: current state of knowledge 2018
- Transcription factor 21 regulates expression of ERβ and SF-1 via upstream stimulatory factor-2 in endometriotic tissues 2018
- The peritoneum: healing, immunity, and diseases 2017
- Progesterone Alleviates Endometriosis via Inhibition of Uterine Cell Proliferation, Inflammation and Angiogenesis in an Immunocompetent Mouse Model 2016
- Estrogen-Induced CCN1 Is Critical for Establishment of Endometriosis-Like Lesions in Mice 2014
- A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis 2012
- Physiologic activation of nuclear factor kappa-B in the endometrium during the menstrual cycle is altered in endometriosis patients 2011
- Estrogen biosynthesis and signaling in endometriosis 2011
- Involvement of the nuclear factor-kB pathway in the pathogenesis of endometriosis 2010
- Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis 2010
- Molecular profiling of human endometrium and endometriosis 2010
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:14:05.573375+00:00